JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SN
2476
DELISTED
Sanchez Energy Corporation
SN
| $5.63M | ﹤0.01% |
1,061,198
-728,026
| -41% | -$3.44M |
2015 Q4
8 quarters
|
|
|
LSXMK
2477
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $5.63M | ﹤0.01% |
186,341
-172,506
| -48% | -$5.47M |
2016 Q2
6 quarters
|
|
2478
Fidelity National Financial
FNF
$10.5B
| $5.63M | ﹤0.01% |
149,084
-545,712
| -79% | -$19.9M |
2013 Q2
18 quarters
|
|
|
CBL
2479
DELISTED
CBL& Associates Properties, Inc.
CBL
| $5.61M | ﹤0.01% |
990,729
-931,408
| -48% | -$6.23M |
2013 Q2
18 quarters
|
|
2480
CALL
RH
RH
$2.31B
| $5.6M | ﹤0.01% |
65,000
+15,000
| +30% | +$1.36M |
2017 Q2
2 quarters
|
|
2481
Aramark
ARMK
$14.7B
| $5.59M | ﹤0.01% |
181,147
-2,082,494
| -92% | -$63.7M |
2013 Q4
16 quarters
|
|
2482
VictoryShares US 500 Volatility Wtd ETF
CFA
$512M
| $5.59M | ﹤0.01% |
114,521
+41,267
| +56% | +$1.95M |
2017 Q3
1 quarter
|
|
2483
Bio-Techne
TECH
$11.4B
| $5.58M | ﹤0.01% |
172,376
+167,468
| +3,412% | +$5.32M |
2015 Q3
9 quarters
|
|
|
CACG
2484
DELISTED
Legg Mason ETF Investment Trust ClearBridge All Cap Growth ESG ETF
CACG
| $5.58M | ﹤0.01% |
199,974
| – | – |
2017 Q2
2 quarters
|
|
|
MANT
2485
DELISTED
Mantech International Corp
MANT
| $5.58M | ﹤0.01% |
111,177
-46,951
| -30% | -$2.28M |
2015 Q4
8 quarters
|
|
|
CPRX
2486
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.58M | ﹤0.01% |
1,426,920
-82,580
| -5% | -$273K |
2017 Q1
3 quarters
|
|
|
PENG
2487
Penguin Solutions Inc
PENG
$3.11B
| $5.55M | ﹤0.01% |
329,200
+175,554
| +114% | +$2.78M |
2017 Q3
1 quarter
|
|
|
WFT
2488
DELISTED
Weatherford International plc
WFT
| $5.55M | ﹤0.01% |
1,329,930
+170,179
| +15% | +$628K |
2014 Q3
13 quarters
|
|
2489
PUT
Martin Marietta Materials
MLM
$34.4B
| $5.53M | ﹤0.01% |
+25,000
| New | +$5.23M |
2017 Q4
0 quarters
|
|
|
HI
2490
DELISTED
Hillenbrand
HI
| $5.52M | ﹤0.01% |
123,473
+24,104
| +24% | +$1.01M |
2015 Q4
8 quarters
|
|
|
NATI
2491
DELISTED
National Instruments Corp
NATI
| $5.51M | ﹤0.01% |
132,484
+128,456
| +3,189% | +$5.61M |
2013 Q2
18 quarters
|
|
2492
CALL
NextEra Energy
NEE
$161B
| $5.51M | ﹤0.01% |
141,200
+73,200
| +108% | +$2.83M |
2017 Q1
3 quarters
|
|
2493
CALL
Texas Instruments
TXN
$271B
| $5.51M | ﹤0.01% |
52,800
-59,600
| -53% | -$5.8M |
2017 Q1
3 quarters
|
|
|
LOXO
2494
DELISTED
Loxo Oncology, Inc
LOXO
| $5.51M | ﹤0.01% |
65,431
+57,231
| +698% | +$4.77M |
2015 Q4
8 quarters
|
|
|
ATHN
2495
DELISTED
Athenahealth, Inc.
ATHN
| $5.51M | ﹤0.01% |
41,404
-101,786
| -71% | -$13M |
2013 Q2
18 quarters
|
|
2496
New York Times
NYT
$9.92B
| $5.49M | ﹤0.01% |
296,704
-242,996
| -45% | -$4.51M |
2016 Q4
4 quarters
|
|
|
MRSN
2497
DELISTED
Mersana Therapeutics
MRSN
| $5.48M | ﹤0.01% |
13,347
-67
| -0.5% | -$29.2K |
2017 Q2
2 quarters
|
|
|
TRTN
2498
DELISTED
Triton International Limited
TRTN
| $5.48M | ﹤0.01% |
+146,277
| New | +$5.63M |
2017 Q4
0 quarters
|
|
|
BITA
2499
DELISTED
Bitauto Holdings Limited
BITA
| $5.47M | ﹤0.01% |
172,005
+157,449
| +1,082% | +$6.42M |
2014 Q2
14 quarters
|
|
|
SPPI
2500
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $5.46M | ﹤0.01% |
287,965
+235,224
| +446% | +$4.26M |
2016 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.